RxDoctor Payments Data

Megan Christenberry

Psychiatric/Mental Health · Murfreesboro, TNNPI 1245871680

Payments from drug & device makers

$4,923in general payments, 2019–2025

Across 243 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$608
  • Otsuka America Pharmaceutical, Inc.$489
  • AbbVie$467
  • Vanda Pharmaceuticals Inc.$464
  • Corium, LLC$395
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$393
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$4,923100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,923 in reported general payments places this provider in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyvanseLisdexamfetamine Dimesylate12$4,577
Aripiprazole82$3,677
Desvenlafaxine Succinate ErDesvenlafaxine Succinate44$2,843
Vilazodone Hcl12$1,836
Bupropion XlBupropion Hcl50$1,706
AmantadineAmantadine Hcl12$1,109
Divalproex Sodium ErDivalproex Sodium19$995
Buspirone Hcl54$930
Duloxetine Hcl33$815
Prazosin Hcl34$616
Oxcarbazepine17$550
Trazodone Hcl74$488
Hydroxyzine Hcl23$477
Amitriptyline Hcl20$445
Lamotrigine53$438

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$258$4,57712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →